Literature DB >> 10792101

Optical coherence tomography as a method for identifying benign and malignant microscopic structures in the prostate gland.

A V D'Amico1, M Weinstein, X Li, J P Richie, J Fujimoto.   

Abstract

OBJECTIVES: Optical coherence tomography (OCT) is a new optical imaging technique capable of providing cross-sectional imaging of tissue microstructure in vivo and in real time. OCT was used in the setting of the human prostate ex vivo, and the images acquired were compared with those obtained using standard histopathologic methods.
METHODS: Multiple samples (3 to 6) were obtained from the radical prostatectomy specimens of 7 men with clinically localized (T1c-2, N0, M0) adenocarcinoma of the prostate. These specimens were 1 cm in length and 1 mm x 1 mm in rectangular cross section. Specimens were first imaged using OCT and then embedded and stained in preparation for histopathologic evaluation. Co-registration of the images obtained using OCT and standard histopathologic evaluation provided the basis for comparison.
RESULTS: Structural architecture on the order of 50 to 150 microm within benign glandular epithelium, fibroadipose tissue, and malignant glandular epithelium could be resolved to a depth of approximately 0.5 mm using OCT.
CONCLUSIONS: Microscopic resolution is possible in human prostatic tissue using OCT. Further studies using this technique to improve the detection and staging of adenocarcinoma of the prostate are ongoing.

Entities:  

Mesh:

Year:  2000        PMID: 10792101     DOI: 10.1016/s0090-4295(00)00475-1

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  17 in total

Review 1.  Fiberoptic imaging for urologic surgery.

Authors:  Jeremy B Tuttle; William D Steers
Journal:  Curr Urol Rep       Date:  2009-01       Impact factor: 3.092

2.  Prostate cancer diagnosis: the feasibility of needle-based optical coherence tomography.

Authors:  Berrend G Muller; Daniel M de Bruin; Willemien van den Bos; Martin J Brandt; Juliette F Velu; Mieke T J Bus; Dirk J Faber; Dilara Savci; Patricia J Zondervan; Theo M de Reijke; Pilar Laguna Pes; Jean de la Rosette; Ton G van Leeuwen
Journal:  J Med Imaging (Bellingham)       Date:  2015-07-09

3.  Optical coherence tomography provides images similar to histology and allows the performance of extensive measurements of drug-eluting metal stents in animal ureters.

Authors:  P Kallidonis; G C Kagadis; P Kitrou; A Tsamandas; I Kyriazis; I Georgiopoulos; D Karnabatidis; S Tsantis; D Liourdi; A Al-Aown; E Liatsikos
Journal:  Lasers Med Sci       Date:  2014-03-04       Impact factor: 3.161

Review 4.  Review of optical coherence tomography in oncology.

Authors:  Jianfeng Wang; Yang Xu; Stephen A Boppart
Journal:  J Biomed Opt       Date:  2017-12       Impact factor: 3.170

5.  Ex vivo imaging of human thyroid pathology using integrated optical coherence tomography and optical coherence microscopy.

Authors:  Chao Zhou; Yihong Wang; Aaron D Aguirre; Tsung-Han Tsai; David W Cohen; James L Connolly; James G Fujimoto
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

Review 6.  Imaging guidance in minimally invasive prostatectomy.

Authors:  Angela D Gupta; Misop Han
Journal:  Urol Oncol       Date:  2011 May-Jun       Impact factor: 3.498

Review 7.  Current and evolving uses of optical coherence tomography in the genitourinary tract.

Authors:  Mohit Gupta; Li-Ming Su
Journal:  Curr Urol Rep       Date:  2015-03       Impact factor: 3.092

8.  Comparing histologic evaluation of prostate tissue using nonlinear microscopy and paraffin H&E: a pilot study.

Authors:  Lucas C Cahill; James G Fujimoto; Michael G Giacomelli; Tadayuki Yoshitake; Yubo Wu; Douglas I Lin; Huihui Ye; Oscar M Carrasco-Zevallos; Andrew A Wagner; Seymour Rosen
Journal:  Mod Pathol       Date:  2019-03-26       Impact factor: 7.842

Review 9.  Novel methods for mapping the cavernous nerves during radical prostatectomy.

Authors:  Nathaniel M Fried; Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2015-08       Impact factor: 14.432

10.  Customized Tool for the Validation of Optical Coherence Tomography in Differentiation of Prostate Cancer.

Authors:  B G Muller; A Swaan; D M de Bruin; W van den Bos; A W Schreurs; D J Faber; E C H Zwartkruis; L Rozendaal; A N Vis; J A Nieuwenhuijzen; R J A van Moorselaar; T G van Leeuwen; J J M C H de la Rosette
Journal:  Technol Cancer Res Treat       Date:  2016-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.